Clinical Trial Update: Dex on Microcirculation in SS-A Double-blinded Study [Phase 4]

View source ↗

Summary

An update on a Phase 4 double-blind trial investigating Dex on microcirculation in septic shock. The status of the study is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Dex

Snippet

Sponsor: Southeast University, China | Conditions: Septic Shock | Phase 4 | Status: UNKNOWN